AstraZeneca Faces Patent Challenge For Best-Selling Drug
Israeli drug maker Teva Pharmaceutical Industries Ltd. is seeking to produce a generic version of the schizophrenia drug Seroquel, which garnered drug originator AstraZeneca $2 billion in worldwide sales last year....To view the full article, register now.
Already a subscriber? Click here to view full article